Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
73,500
Siemens Healthineers AG News & Analysis
personal-finance
Simple but not easy: How to invest as Buffett intended
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,168.00 | 7.10 | -0.08% |
CAC 40 | 7,694.25 | 13.65 | -0.18% |
DAX 40 | 23,682.15 | 355.18 | -1.48% |
Dow JONES (US) | 45,544.88 | 92.02 | -0.20% |
FTSE 100 | 9,153.09 | 43.25 | -0.47% |
HKSE | 25,496.55 | 120.87 | -0.47% |
NASDAQ | 21,455.55 | 249.61 | -1.15% |
Nikkei 225 | 42,310.49 | 121.70 | 0.29% |
NZX 50 Index | 13,133.16 | 62.71 | 0.48% |
S&P 500 | 6,460.26 | 41.60 | -0.64% |
S&P/ASX 200 | 8,900.60 | 1.50 | -0.02% |
SSE Composite Index | 3,858.13 | 17.40 | -0.45% |